Skip to content
AlonBio Ltd.
BKT300-Data Room
04.2.7. Report Number 300-RD-R-95 In Vivo Evaluation of BKT300-N1 once-a-week in Low Passage Champions’ TumorGraft® Model of Breast Cancer (CTG-2518) in Immunocompromised Mice
Scroll to top
AlonBio Ltd.